HA
MYOK

HC Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

HC Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,687
Closed -$230K – 90
2020
Q3 		$230K Sell
1,687
-913
-35% -$97.1K 0.19% 63
2020
Q2 		$251K Buy
+2,600
New +$217K 0.21% 68

HC Advisors's MYOK Position: Q4 2020 in Review

HC Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 1,687 shares — an estimated $230K sold.

HC Advisors first reported a position in MYOK in Q2 2020 and held it in 2 quarters. The position peaked at $251K in Q2 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • HC Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • HC Advisors sold 1,687 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $230K.
  • HC Advisors first reported a position in MyoKardia, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • HC Advisors's MyoKardia, Inc. Common Stock position peaked at $251K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on HC Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.